Abstract
Bacillus Calmette Guerin (BCG) is widely used for prevention of recurrence and progression in non-muscle invasive urinary bladder cancers. However, it is associated with tolerable adverse events ranging from low-grade fever to lower urinary tract symptoms. While majority of complications are minor and local, systemic involvement warrants early treatment with antitubercular agents. Involvement of glans penis is rare with only few cases reported in the literature. We report one such case of BCG balanitis in a 64-year-old male treated with intravesical BCG for non-muscle invasive urinary bladder cancer.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
